Literature DB >> 4923642

Evaluation of the effects of isoprenaline and salbutamol aerosols on airways obstruction and pulse rates of children with asthma.

G Hambleton, E A Shinebourne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4923642      PMCID： PMC1647441          DOI： 10.1136/adc.45.244.766

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  7 in total

1.  Cardiovascular effects of AH.3365 (salbutamol).

Authors:  G R Kelman; K N Palmer; M R Cross
Journal:  Nature       Date:  1969-03-29       Impact factor: 49.962

2.  Clinical trial of a new B-adrenergic stimulant in asthma.

Authors:  W D Riding; S S Chatterjee; P Dinda
Journal:  Br J Clin Pract       Date:  1969-05

3.  Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator.

Authors:  M C Kennedy; W T Simpson
Journal:  Br J Dis Chest       Date:  1969-07

4.  New class of selective stimulants of beta-adrenergic receptors.

Authors:  D Hartley; D Jack; L H Lunts; A C Ritchie
Journal:  Nature       Date:  1968-08-24       Impact factor: 49.962

5.  Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma.

Authors:  K N Palmer; M L Diament
Journal:  Br Med J       Date:  1969-01-04

6.  Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma.

Authors:  Y F Choo-Kang; W T Simpson; I W Grant
Journal:  Br Med J       Date:  1969-05-03

7.  Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.

Authors:  V A Cullum; J B Farmer; D Jack; G P Levy
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739
  7 in total
  6 in total

1.  Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

Authors:  H Minatoya; B A Spilker
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  Bronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthma.

Authors:  A D Milner; D Ingram
Journal:  Arch Dis Child       Date:  1971-08       Impact factor: 3.791

3.  Use of serial exercise tests to assess the efficacy and duration of action of drugs for asthma.

Authors:  M Silverman; P Konig; S Godfrey
Journal:  Thorax       Date:  1973-09       Impact factor: 9.139

4.  Use of salbutamol powder in childhood asthma.

Authors:  W Lenney; A D Milner; E J Hiller
Journal:  Arch Dis Child       Date:  1978-12       Impact factor: 3.791

5.  Protective effect of inhaled salbutamol powder in children assessed by histamine challenge.

Authors:  C R Pullan; A J Martin
Journal:  Br Med J       Date:  1980-02-09

6.  How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children? Study protocol for a randomised controlled trial.

Authors:  Somnath Mukhopadhyay; Paul Seddon; Gemma Earl; Emma Wileman; Liz Symes; Cathy Olden; Corinne Alberti; Stephen Bremner; Alison Lansley; Colin N A Palmer; Nicole Beydon
Journal:  Trials       Date:  2016-11-11       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.